Germany Chronic Kidney Disease Nutritional Supplement Market Insight
Published: 22 May 2026 | Report Format: Electronic (PDF)
Germany’s chronic kidney disease nutritional supplement market is advancing through renal-specific formulas with controlled protein, potassium, phosphorus, and personalized nutrition support integrated into dialysis and home care.
Germany Chronic Kidney Disease Nutritional Supplement Market Insights and Forecasts to 2035
- In 2025, the Germany Chronic Kidney Disease Nutritional Supplement Market stood at USD 96.4 Million, establishing a strong base for future growth.
- It is anticipated to expand at a CAGR of 7.4% over 2025 to 2035, supported by a healthy expansion trend.
- The market is projected to reach USD 196.8 Million by 2035, reflecting continuous long-term growth.
Notable Insights for the Germany Chronic Kidney Disease Nutritional Supplement Market
- By Product Type, oral nutritional supplements (ONS) dominate the market by a 62-64% share. ONS dominate due to the convenience offered to provide daily nutritional requirements for dialysis and pre-dialysis patients.
- By patient type, hemodialysis patients dominate the market by 52-54% share. The unique nutritional needs of hemodialysis patients include high protein and electrolyte control.
- Fresenius SE & Co. KGaA increased clinical nutrition innovation and manufacturing investments, with group capital expenditure exceeding EUR 1.2 billion (approximately USD 1.3 billion) in 2025.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Germany chronic kidney disease nutritional supplement market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Germany Chronic Kidney Disease Nutritional Supplement Market
- Fresenius Kabi AG
- Fresenius Medical Care AG
- B. Braun SE
- Nestlé Health Science
- Danone Nutricia
- Abbott Laboratories
- Baxter International
- Medice Arzneimittel Putter GmbH & Co. KG
- Victus, Inc.
- Smartfish AS
Recent Developments:
- In February 2026, Fresenius Kabi introduced new enteral nutrition products in multiple places across Europe, with formulations that support certain conditions, and they are also safe for renal patients to use in Germany.
- In September 2024, Danone, brought its specialised medical nutrition activities in Europe. Also supported Nutricia range in renal nutrition and in hospital settings more robust in Germany.
Market Segmentation:
Germany Chronic Kidney Disease Nutritional Supplement Market, By Product Type
- Oral Nutritional Supplements
- Enteral Tube Feeding Formulas
- Powdered Renal Nutrition Supplements
Germany Chronic Kidney Disease Nutritional Supplement Market, By Patient Group
- Pre-Dialysis CKD
- Hemodialysis
- Peritoneal Dialysis
Germany Chronic Kidney Disease Nutritional Supplement Market, By Distribution Channel
- Hospitals and Dialysis Centers
- Retail Pharmacies
- Online and Home Healthcare Providers
Research Methodologies Used to Analyse Germany's Chronic Kidney Disease Nutritional Supplement Market
This research utilises sources such as company annual reports, nephrology guidelines, reimbursement policies, dialysis numbers, import/export figures, and new product introductions. Interviews conducted with nephrologists, renal nutritionists, and dialysis centres enable forecasting based on CKD prevalence, supplementation rates, price movements, and financial results from companies.
Expert Views:
The German CKD nutritional supplement market is growing since renal nutrition has become a key aspect of managing the condition. The oral nutritional supplements category continues to dominate since they are easily consumable and accepted clinically. Electrolyte-balanced innovations will fuel growth until 2035.
Author: Komal and Radhika By Spherical Insights and Consulting